Statistics for the Plotted Points |
11-KETOTESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 108% | 21% | 108% | 22% |
>= Reporting Level | 4 | 63% | 4% | 65% | 4% |
Total | 8 | 86% | 28% | 75% | 32% |
Miscellaneous Statistics for the Samples |
11-KETOTESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 8 | 62% | Spiked |
Estimated Values | 1 | 8% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 3 | 23% | Spiked |
Spiked | 13 | . | |
False Negatives | 2 | 15% | 2 out of 13 |
Not Spiked | 55 | . | |
False Positives | 1 | 2% | 1 out of 54 |
Statistics for the Plotted Points |
17-ALPHA-ESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 30 | 87% | 15% | 86% | 12% |
Total | 30 | 87% | 15% | 86% | 12% |
Miscellaneous Statistics for the Samples |
17-ALPHA-ESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 30 | 97% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 31 | . | |
False Negatives | 1 | 3% | 1 out of 31 |
Not Spiked | 37 | . | |
False Positives | 0 | 0% | 0 out of 37 |
Statistics for the Plotted Points |
17-ALPHA-ETHYNYLESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 28 | 82% | 18% | 81% | 15% |
Total | 28 | 82% | 18% | 81% | 15% |
Miscellaneous Statistics for the Samples |
17-ALPHA-ETHYNYLESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 28 | 90% | Spiked |
Estimated Values | 4 | 13% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 3% | Spiked |
Spiked | 31 | . | |
False Negatives | 2 | 6% | 2 out of 31 |
Not Spiked | 37 | . | |
False Positives | 0 | 0% | 0 out of 37 |
Statistics for the Plotted Points |
17-BETA-ESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 31 | 90% | 18% | 90% | 20% |
Total | 31 | 90% | 18% | 90% | 20% |
Miscellaneous Statistics for the Samples |
17-BETA-ESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 31 | 100% | Spiked |
Estimated Values | 2 | 6% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 31 | . | |
False Negatives | 0 | 0% | 0 out of 31 |
Not Spiked | 37 | . | |
False Positives | 1 | 3% | 1 out of 37 |
Statistics for the Plotted Points |
NORETHINDRONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 105% | . | 105% | 0% |
>= Reporting Level | 27 | 94% | 19% | 92% | 15% |
Total | 28 | 94% | 19% | 93% | 14% |
Miscellaneous Statistics for the Samples |
NORETHINDRONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 28 | 90% | Spiked |
Estimated Values | 7 | 23% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 31 | . | |
False Negatives | 3 | 10% | 3 out of 31 |
Not Spiked | 37 | . | |
False Positives | 0 | 0% | 0 out of 36 |
Statistics for the Plotted Points |
3-BETA-COPROSTANOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 22 | 100% | 41% | 91% | 14% |
Total | 22 | 100% | 41% | 91% | 14% |
Miscellaneous Statistics for the Samples |
3-BETA-COPROSTANOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 22 | 100% | Spiked |
Estimated Values | 3 | 14% | Spiked |
Deleted Values | 7 | 12% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 25 | . | |
False Negatives | 0 | 0% | 0 out of 22 |
Not Spiked | 32 | . | |
False Positives | 6 | 21% | 6 out of 28 |
Statistics for the Plotted Points |
4-ANDROSTENE-3,17-DIONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 7 | 103% | 11% | 106% | 18% |
Total | 7 | 103% | 11% | 106% | 18% |
Miscellaneous Statistics for the Samples |
4-ANDROSTENE-3,17-DIONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 7 | 88% | Spiked |
Estimated Values | 1 | 13% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 13% | Spiked |
Spiked | 8 | . | |
False Negatives | 0 | 0% | 0 out of 8 |
Not Spiked | 60 | . | |
False Positives | 2 | 3% | 2 out of 59 |
Statistics for the Plotted Points |
CHOLESTEROL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 22 | 116% | 44% | 103% | 14% |
Total | 22 | 116% | 44% | 103% | 14% |
Miscellaneous Statistics for the Samples |
CHOLESTEROL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 22 | 100% | Spiked |
Estimated Values | 2 | 9% | Spiked |
Deleted Values | 7 | 12% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 25 | . | |
False Negatives | 0 | 0% | 0 out of 22 |
Not Spiked | 32 | . | |
False Positives | 6 | 21% | 6 out of 28 |
Statistics for the Plotted Points |
CIS-ANDROSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 28 | 91% | 27% | 85% | 17% |
Total | 28 | 91% | 27% | 85% | 17% |
Miscellaneous Statistics for the Samples |
CIS-ANDROSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 28 | 93% | Spiked |
Estimated Values | 7 | 23% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 3% | Spiked |
Spiked | 30 | . | |
False Negatives | 1 | 3% | 1 out of 30 |
Not Spiked | 38 | . | |
False Positives | 0 | 0% | 0 out of 37 |
Statistics for the Plotted Points |
TRANS-DIETHYLSTILBESTROL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 80% | . | 80% | 0% |
>= Reporting Level | 30 | 78% | 20% | 82% | 19% |
Total | 31 | 78% | 19% | 81% | 19% |
Miscellaneous Statistics for the Samples |
TRANS-DIETHYLSTILBESTROL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 31 | 84% | Spiked |
Estimated Values | 3 | 8% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 38 | . | |
False Negatives | 6 | 16% | 6 out of 37 |
Not Spiked | 30 | . | |
False Positives | 0 | 0% | 0 out of 30 |
Statistics for the Plotted Points |
EPITESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 58% | 18% | 52% | 5% |
>= Reporting Level | 19 | 93% | 29% | 90% | 18% |
Total | 24 | 86% | 30% | 82% | 19% |
Miscellaneous Statistics for the Samples |
EPITESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 24 | 100% | Spiked |
Estimated Values | 8 | 33% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 25 | . | |
False Negatives | 0 | 0% | 0 out of 24 |
Not Spiked | 43 | . | |
False Positives | 2 | 5% | 2 out of 43 |
Statistics for the Plotted Points |
EQUILENIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 27 | 64% | 30% | 66% | 33% |
Total | 27 | 64% | 30% | 66% | 33% |
Miscellaneous Statistics for the Samples |
EQUILENIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 27 | 87% | Spiked |
Estimated Values | 10 | 32% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 3% | Spiked |
Spiked | 31 | . | |
False Negatives | 3 | 10% | 3 out of 31 |
Not Spiked | 37 | . | |
False Positives | 6 | 16% | 6 out of 37 |
Statistics for the Plotted Points |
EQUILIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 27 | 67% | 36% | 66% | 25% |
Total | 27 | 67% | 36% | 66% | 25% |
Miscellaneous Statistics for the Samples |
EQUILIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 27 | 77% | Spiked |
Estimated Values | 27 | 77% | Spiked |
Deleted Values | 2 | 3% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 37 | . | |
False Negatives | 8 | 23% | 8 out of 35 |
Not Spiked | 31 | . | |
False Positives | 0 | 0% | 0 out of 31 |
Statistics for the Plotted Points |
ESTRIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 9 | 96% | 41% | 84% | 9% |
>= Reporting Level | 25 | 80% | 27% | 67% | 20% |
Total | 34 | 84% | 31% | 77% | 20% |
Miscellaneous Statistics for the Samples |
ESTRIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 34 | 81% | Spiked |
Estimated Values | 10 | 24% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 3 | 7% | Spiked |
Spiked | 43 | . | |
False Negatives | 5 | 12% | 5 out of 42 |
Not Spiked | 25 | . | |
False Positives | 3 | 12% | 3 out of 25 |
Statistics for the Plotted Points |
ESTRONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 35 | 110% | 25% | 109% | 18% |
Total | 35 | 110% | 25% | 109% | 18% |
Miscellaneous Statistics for the Samples |
ESTRONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 35 | 92% | Spiked |
Estimated Values | 5 | 13% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 2 | 5% | Spiked |
Spiked | 38 | . | |
False Negatives | 1 | 3% | 1 out of 38 |
Not Spiked | 30 | . | |
False Positives | 0 | 0% | 0 out of 29 |
Statistics for the Plotted Points |
MESTRANOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 143% | . | 143% | 0% |
>= Reporting Level | 32 | 102% | 49% | 82% | 56% |
Total | 33 | 103% | 49% | 84% | 55% |
Miscellaneous Statistics for the Samples |
MESTRANOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 33 | 87% | Spiked |
Estimated Values | 3 | 8% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 2 | 5% | Spiked |
Spiked | 38 | . | |
False Negatives | 3 | 8% | 3 out of 38 |
Not Spiked | 30 | . | |
False Positives | 0 | 0% | 0 out of 30 |
Statistics for the Plotted Points |
PROGESTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 15 | 84% | 42% | 87% | 33% |
>= Reporting Level | 12 | 63% | 39% | 50% | 8% |
Total | 27 | 75% | 42% | 55% | 34% |
Miscellaneous Statistics for the Samples |
PROGESTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 27 | 73% | Spiked |
Estimated Values | 27 | 73% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 9 | 24% | Spiked |
Spiked | 37 | . | |
False Negatives | 1 | 3% | 1 out of 37 |
Not Spiked | 31 | . | |
False Positives | 0 | 0% | 0 out of 31 |
Statistics for the Plotted Points |
DIHYDROTESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 11 | 142% | 54% | 156% | 85% |
>= Reporting Level | 12 | 70% | 39% | 65% | 8% |
Total | 23 | 104% | 58% | 79% | 72% |
Miscellaneous Statistics for the Samples |
DIHYDROTESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 23 | 96% | Spiked |
Estimated Values | 8 | 33% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 4% | Spiked |
Spiked | 24 | . | |
False Negatives | 0 | 0% | 0 out of 24 |
Not Spiked | 44 | . | |
False Positives | 0 | 0% | 0 out of 44 |
Statistics for the Plotted Points |
TESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 13 | 99% | 18% | 94% | 14% |
Total | 13 | 99% | 18% | 94% | 14% |
Miscellaneous Statistics for the Samples |
TESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 13 | 100% | Spiked |
Estimated Values | 2 | 15% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 13 | . | |
False Negatives | 0 | 0% | 0 out of 13 |
Not Spiked | 55 | . | |
False Positives | 0 | 0% | 0 out of 54 |